Lanfranco Pellesi

1.5k total citations
54 papers, 825 citations indexed

About

Lanfranco Pellesi is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Lanfranco Pellesi has authored 54 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Psychiatry and Mental health, 30 papers in Pathology and Forensic Medicine and 21 papers in Physiology. Recurrent topics in Lanfranco Pellesi's work include Migraine and Headache Studies (47 papers), Trigeminal Neuralgia and Treatments (22 papers) and Sympathectomy and Hyperhidrosis Treatments (17 papers). Lanfranco Pellesi is often cited by papers focused on Migraine and Headache Studies (47 papers), Trigeminal Neuralgia and Treatments (22 papers) and Sympathectomy and Hyperhidrosis Treatments (17 papers). Lanfranco Pellesi collaborates with scholars based in Italy, Denmark and China. Lanfranco Pellesi's co-authors include Simona Guérzoni, Luigi Alberto Pini, Messoud Ashina, Carlo Baraldi, Silvia Benemei, Paolo Martelletti, Mohammad Al‐Mahdi Al‐Karagholi, Anne Luise Haulund Vollesen, Jens Hannibal and Faisal Mohammad Amin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Pain.

In The Last Decade

Lanfranco Pellesi

48 papers receiving 808 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lanfranco Pellesi 639 390 250 116 111 54 825
Alejandro Labastida‐Ramírez 707 1.1× 359 0.9× 224 0.9× 73 0.6× 160 1.4× 30 893
Eloísa Rubio‐Beltrán 784 1.2× 422 1.1× 279 1.1× 176 1.5× 124 1.1× 35 1.1k
Kerri Wilks 507 0.8× 324 0.8× 321 1.3× 41 0.4× 104 0.9× 9 709
Cristiana Rossi 521 0.8× 183 0.5× 205 0.8× 75 0.6× 62 0.6× 18 790
Katherine J. Selzler 645 1.0× 401 1.0× 295 1.2× 31 0.3× 81 0.7× 18 795
P Tfelt-Hansen 845 1.3× 476 1.2× 386 1.5× 60 0.5× 94 0.8× 15 1.0k
Anja Sofie Petersen 679 1.1× 474 1.2× 373 1.5× 50 0.4× 52 0.5× 41 821
R. Cerbo 618 1.0× 349 0.9× 238 1.0× 48 0.4× 128 1.2× 44 770
Michail Vikelis 648 1.0× 388 1.0× 274 1.1× 45 0.4× 158 1.4× 63 977
Tricia Blankenbiller 893 1.4× 620 1.6× 367 1.5× 42 0.4× 87 0.8× 8 962

Countries citing papers authored by Lanfranco Pellesi

Since Specialization
Citations

This map shows the geographic impact of Lanfranco Pellesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanfranco Pellesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanfranco Pellesi more than expected).

Fields of papers citing papers by Lanfranco Pellesi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanfranco Pellesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanfranco Pellesi. The network helps show where Lanfranco Pellesi may publish in the future.

Co-authorship network of co-authors of Lanfranco Pellesi

This figure shows the co-authorship network connecting the top 25 collaborators of Lanfranco Pellesi. A scholar is included among the top collaborators of Lanfranco Pellesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanfranco Pellesi. Lanfranco Pellesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pellesi, Lanfranco, et al.. (2026). Mapping the immune and epigenetic landscape of medication-overuse headache (MOH): a systematic review. Frontiers in Immunology. 17. 1756442–1756442.
2.
Baraldi, Carlo, et al.. (2025). Fremanezumab for the Treatment of Migraine Complicated by Medication Overuse: A Systematic Review. Clinical Drug Investigation. 45(5). 247–254.
3.
Pellesi, Lanfranco. (2025). Trust in AI Feedback: Challenges in Pharmacy Education. Medical Science Educator. 35(5). 2615–2619.
4.
Pellesi, Lanfranco & Lars Edvinsson. (2025). Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success. The Journal of Headache and Pain. 26(1). 22–22. 7 indexed citations
5.
Pellesi, Lanfranco, et al.. (2025). Adoption of rimegepant in Denmark: a register-based study on uptake, prescribing patterns and initiator characteristics. The Journal of Headache and Pain. 26(1). 83–83. 3 indexed citations
6.
Beier, Dagmar, et al.. (2024). Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review. The Journal of Headache and Pain. 25(1). 112–112. 23 indexed citations
7.
8.
Stage, Tore Bjerregaard, et al.. (2024). Migraine-inducing effects of sildenafil in men with migraine without aura: Protocol for a randomized, placebo-controlled crossover trial. SHILAP Revista de lepidopterología. 7. 2 indexed citations
9.
Wells-Gatnik, William, Lanfranco Pellesi, & Paolo Martelletti. (2024). Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine. Expert Review of Neurotherapeutics. 24(11). 1107–1117. 9 indexed citations
10.
Pellesi, Lanfranco, David García‐Azorín, Eloísa Rubio‐Beltrán, et al.. (2024). Combining treatments for migraine prophylaxis: the state-of-the-art. The Journal of Headache and Pain. 25(1). 214–214. 16 indexed citations
11.
Pellesi, Lanfranco, Dilara Onan, & Paolo Martelletti. (2024). Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies?. Toxins. 16(10). 427–427. 2 indexed citations
12.
Pellesi, Lanfranco. (2023). Combining onabotulinumtoxin A with a CGRP antagonist for chronic migraine prophylaxis: where do we stand?. SHILAP Revista de lepidopterología. 4. 1292994–1292994. 2 indexed citations
13.
Deligianni, Christina, Lanfranco Pellesi, Basit Ali Chaudhry, et al.. (2023). Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study. Frontiers in Neurology. 14. 1135246–1135246. 5 indexed citations
14.
Cvetković, Vlasta Vuković, Roberto De Icco, Thien Phu, et al.. (2021). Greater Occipital Nerve Block with Local Anesthetics and Corticosteroids in Treatment-Resistant Chronic Migraine. Research at the University of Copenhagen (University of Copenhagen). 12(3). 160–167. 1 indexed citations
15.
Pellesi, Lanfranco, et al.. (2020). Reducing Episodic Cluster Headaches: Focus on Galcanezumab. SHILAP Revista de lepidopterología.
16.
Lupi, Chiara, Valentina Favoni, Antonio Granato, et al.. (2018). Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare Network. Cephalalgia. 38(8). 1429–1441. 14 indexed citations
17.
Pellesi, Lanfranco, Manuela Licata, Federica Palazzoli, et al.. (2018). Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study. European Journal of Clinical Pharmacology. 74(11). 1427–1436. 33 indexed citations
18.
Benemei, Silvia, Francesca Cortese, Alejandro Labastida‐Ramírez, et al.. (2017). Triptans and CGRP blockade – impact on the cranial vasculature. The Journal of Headache and Pain. 18(1). 103–103. 56 indexed citations
19.
Guérzoni, Simona, Lanfranco Pellesi, Carlo Baraldi, et al.. (2017). Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy. Frontiers in Neurology. 8. 586–586. 41 indexed citations
20.
Guérzoni, Simona, Lanfranco Pellesi, Carlo Baraldi, & Luigi Alberto Pini. (2016). Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment. The Journal of Headache and Pain. 17(1). 48–48. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro Labastida‐Ramírez Breakdown of academic impact, for papers by Eloísa Rubio‐Beltrán Breakdown of academic impact, for papers by Kerri Wilks Breakdown of academic impact, for papers by Cristiana Rossi Breakdown of academic impact, for papers by Katherine J. Selzler Breakdown of academic impact, for papers by P Tfelt-Hansen Breakdown of academic impact, for papers by Anja Sofie Petersen Breakdown of academic impact, for papers by R. Cerbo Breakdown of academic impact, for papers by Michail Vikelis Breakdown of academic impact, for papers by Tricia Blankenbiller
Rankless by CCL
2026